SYNLOGIC INC.     DL-,001
SYNLOGIC INC. DL-,001
Share · US87166L2097 · SYBX · A3EWCN (XNCM)
Overview Financial Indicators
1,13 EUR
1,98 % 0,02 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 19:09

Current Prices from SYNLOGIC INC. DL-,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SYBX
USD
10.06.2025 19:09
1,29 USD
1,27 USD
+1,98 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 5,05 % 9,73 % -2,25 % -20,49 % -22,80 % -96,30 %

Company Profile for SYNLOGIC INC. DL-,001 Share

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

Company Data

Name SYNLOGIC INC. DL-,001
Company Synlogic, Inc.
Symbol SYBX
Website https://www.synlogictx.com
Primary Exchange XNCM Frankfurt
WKN A3EWCN
ISIN US87166L2097
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ms. Mary Beth Dooley
Market Capitalization 12 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 301 Binney Street, 02142 Cambridge
IPO Date 2015-09-30

ID Changes

Date From To
30.08.2017 MIRN SYBX

Ticker Symbols

Name Symbol
NASDAQ SYBX

More Shares

Investors who SYNLOGIC INC. DL-,001 hold also have the following shares in their portfolio:
American Financial Group, Inc. 4.500% Subordinated Debentures due 2060
American Financial Group, Inc. 4.500% Subordinated Debentures due 2060 Share
LB.HESS.THR.CARRARA01G/18
LB.HESS.THR.CARRARA01G/18 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025